BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9647588)

  • 1. The alpha subunit of inhibin in adrenal cortical neoplasia.
    Pelkey TJ; Frierson HF; Mills SE; Stoler MH
    Mod Pathol; 1998 Jun; 11(6):516-24. PubMed ID: 9647588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
    Sangoi AR; McKenney JK
    Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
    Renshaw AA; Granter SR
    Mod Pathol; 1998 Dec; 11(12):1160-4. PubMed ID: 9872645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
    Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
    Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
    Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
    Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
    Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
    Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
    Elmoneim HM; Samaka RM; Ali H
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoexpression of inhibin alpha-subunit in adrenal neoplasms.
    Cho EY; Ahn GH
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):222-8. PubMed ID: 11556749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.
    McCluggage WG; Burton J; Maxwell P; Sloan JM
    J Clin Pathol; 1998 Feb; 51(2):114-6. PubMed ID: 9602683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
    Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
    J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
    Miettinen M
    Lab Invest; 1992 Feb; 66(2):169-74. PubMed ID: 1735954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
    Fetsch PA; Powers CN; Zakowski MF; Abati A
    Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoid adrenal cortical neoplasms.
    Raparia K; Ayala AG; Sienko A; Zhai QJ; Ro JY
    Ann Diagn Pathol; 2008 Oct; 12(5):344-8. PubMed ID: 18774497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The expression of A103 and inhibin alpha in adrenocortical adenoma by high-throughput tissue microarray techniques].
    Zhang H; Liu W; Wang X; Li G; Guo J; Li F; Liao D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):424-6. PubMed ID: 12910679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis.
    Kumar D; Kumar S
    Mod Pathol; 1993 Jan; 6(1):36-41. PubMed ID: 7678935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
    Browning L; Bailey D; Parker A
    J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-inhibin immunoreactivity in soft-tissue neoplasia.
    Schraith DF; Hahm GK; Niemann TH; DeYoung BR
    Mod Pathol; 2003 Dec; 16(12):1205-9. PubMed ID: 14681320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.